Fingerprint
Dive into the research topics of 'Long-term results of NRG oncology RTOG 0617: Standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically